Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention Among Postmenopausal Women

OBJECTIVE: To better understand the potential risk/benefit ratio for targeted chemoprevention, we evaluated the association of aspirin and other NSAIDs with incidence of postmenopausal breast cancer for risk subgroups defined by selected non-modifiable or difficult-to-modify breast cancer risk facto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mayo Clin Proc
Egile Nagusiak: Bardia, Aditya, Keenan, Tanya E., Ebbert, Jon O., Lazovich, DeAnn, Wang, Alice H., Vierkant, Robert A., Olson, Janet E., Vachon, Celine M., Limburg, Paul J., Anderson, Kristin E., Cerhan, James R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4807132/
https://ncbi.nlm.nih.gov/pubmed/26678006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2015.10.018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak